Analytical evaluation of a rapid on-site oral fluid drug test

Goessaert, An-Sofie; Pil, Kristof; Veramme, Jolien; Verstraete, Alain
April 2010
Analytical & Bioanalytical Chemistry;Apr2010, Vol. 396 Issue 7, p2461
Academic Journal
There is a need for a reliable rapid on-site oral fluid test that can be used in police controls to detect impaired drivers. We evaluated the Varian Oralab®6 and collected two oral fluid samples from 250 subjects, one with the Varian Oralab®6 and one with the StatSure™ Saliva•Sampler™. The Oralab®6 can detect six drug types: amphetamines, methamphetamine, cocaine, opiates, delta9-tetrahydrocannabinol (THC), and phencyclidine (PCP). On-site results were obtained within 10 to 15 min. The sample collected with StatSure™ was analyzed using liquid chromatography–tandem mass spectrometry after liquid–liquid extraction and these results were used as a reference to determine prevalence, sensitivity, and specificity. Two cut-off values were used in the evaluation. The Varian cut-off values were: amphetamine 50 ng/mL, cocaine 20 ng/mL, opiates 40 ng/mL, and THC 50 ng/mL. The DRUID cut-offs were: amphetamine 25 ng/mL, cocaine 20 ng/mL, opiates 20 ng/mL, and THC 1 ng/mL. Applying the first cut-offs, prevalence, sensitivity, and specificity were: amphetamine 10%, 76%, 100%; cocaine 23%, 34%, 100%; opiates 38%, 83%, 94%; and THC 18%, 41%, 99%. The DRUID cut-off values gave the following results: amphetamine 14%, 56%, 100%; cocaine 28%, 34%, 100%; opiates 49%, 68%, 98%, and THC 45%, 16%, 99%. The specificity of the Oralab®6 is generally good. For both cut-offs, sensitivity was low for cocaine and THC. Therefore, the Varian Oralab®6 test is not sensitive enough to be applied during roadside police controls.


Related Articles

  • Researchers develop phone-sized, saliva-based POC diagnostic. Young, Karen // Diagnostics & Imaging Week;4/19/2007, Vol. 10 Issue 16, p1 

    The article focuses on a research which developed a desktop, phone-sized point-of-care diagnostic device called Integrated Microfluid Platform for Oral Diagnostics. Researchers at Sandia National Laboratories developed such device with the belief that it can be use to diagnose oral cancer. The...

  • New rapid test identifies active TB.  // Hospital Employee Health;Dec2010, Vol. 29 Issue 12, p143 

    The article provides information on a new rapid test for the identification of active tuberculosis (TB). It informs that the test, called Xpert MTB/RIF is not available yet in U.S., and it is not approved by U.S. Food and Drug Administration. It further informs that the MTB/RIF amplifies the...

  • Assessment of the performance of a rapid point of care syphilis test in a London genitourinary medicine clinic. Perry, Melissa; Iveson, Helen; White, John // International Journal of STD & AIDS;Nov2014, Vol. 25 Issue 13, p967 

    A letter to the editor is presented in response to the article "Simultaneous triple point-of-care testing for HIV, syphilis and hepatitis B virus to prsyphilis,event mother-to-child transmission in India" by N. P. Pai, J. Kurji, A. Singam, and colleagues.

  • POINT-OF-CARE TESTING. Scalise, Damagra // H&HN: Hospitals & Health Networks;Sep2006, Vol. 80 Issue 9, p75 

    The article presents an overview of point-of-care testing (POCT), its challenges and benefits for hospitals in the U.S. Among the point-of-care tests of most importance for hospitals are tight glycemic control and molecular diagnostics. The adoption of POCT produces several advantages such as...

  • Point-of-care tests eyed in stemming rise in STDs.  // Contraceptive Technology Update;May2010, Vol. 31 Issue 5, p49 

    The author discusses the efficacy of point-of-care (POC) testing for sexually transmitted diseases (STD) that enables clinicians to provide immediate and confidential test results and treatment.

  • OraSure to provide HCV test at Walgreens.  // Medical Device Daily;5/20/2013, Vol. 17 Issue 97, p3 

    The article reports that individuals who may be at risk for hepatitis C virus (HCV) are being offered HCV testing using the Oraquick HCV Rapid Test courtesy of medical technology company OraSure Technologies, retail drug chain Walgreens, and the Chronic Liver Disease Foundation.

  • Rapid point-of-care HIV antibody test recommended in high-risk populations. Pai, Nitika Pant // Infectious Disease News;Mar2012, Vol. 25 Issue 3, p12 

    The article discusses research which recommended a rapid point-of-care HIV test in high-risk populations after comparing the diagnostic accuracy and positive predictive value of OraQuick AdvanceRapid HIV-I/2 Antibody Test when used with oral fluid vs. blood-based specimens in adults.

  • Sensors: Photonic sugar detector. Pleasants, Simon // Nature Photonics;Aug2014, Vol. 8 Issue 8, p585 

    The article discusses an international study published in the 14, 3587-3593 2014 issue of "Nano Letters" which demonstrated a promising photonic nanosensor for diabetes point-of-care screening and urinary tract infection diagnosis.

  • Office rapid strep tests: State of the art. SCHUMAN, ANDREW. J. // Contemporary Pediatrics;Sep2015, Vol. 32 Issue 9, p42 

    The article offers information on rapid antigen detection tests (RADT) which are used by pediatricians in detecting group A streptococcus early in the course of the infection, expediting diagnosis and treatment. Topics include methods of testing swabs for strep used by pediatricians before the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics